MOBICOX DIN 02242786
Health Canada record
| Active ingredient(s) | MELOXICAM 15 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AC06 MELOXICAM |
| Original market date | 26-Sep-2000 |
| Current status date | 17-Aug-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MELOXICAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02248974 | APO-MELOXICAM | APOTEX INC | Tablet | MELOXICAM 15 MG | Marketed |
| 02396467 | APO-MELOXICAM | APOTEX INC | Suspension | MELOXICAM 1.5 G | Marketed |
| 02248973 | APO-MELOXICAM | APOTEX INC | Tablet | MELOXICAM 7.5 MG | Marketed |
| 02390884 | AURO-MELOXICAM | AURO PHARMA INC | Tablet | MELOXICAM 7.5 MG | Marketed |
| 02390892 | AURO-MELOXICAM | AURO PHARMA INC | Tablet | MELOXICAM 15 MG | Marketed |
| 02527871 | BOVICAM 20 | MODERN VETERINARY THERAPEUTICS LLC | Solution | MELOXICAM 20 MG | Marketed |
| 02480689 | INFLACAM CHEWABLE TABLETS | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Tablet (Chewable) | MELOXICAM 2.5 MG | Marketed |
| 02480670 | INFLACAM CHEWABLE TABLETS | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Tablet (Chewable) | MELOXICAM 1 MG | Marketed |
| 02469952 | INFLACAM INJECTION | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Solution | MELOXICAM 5 MG | Marketed |
| 02535491 | LEMICAM CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | MELOXICAM 1 MG | Approved |
| 02535505 | LEMICAM CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | MELOXICAM 2.5 MG | Approved |
| 02487225 | MELOXADIN INJECTION | NORBROOK LABORATORIES LTD. | Solution | MELOXICAM 5 MG | Marketed |
| 02485621 | MELOXADIN ORAL SUSPENSION | NORBROOK LABORATORIES LTD. | Suspension | MELOXICAM 1.5 MG | Marketed |
| 02353148 | MELOXICAM | SANIS HEALTH INC | Tablet | MELOXICAM 7.5 MG | Marketed |
| 02353156 | MELOXICAM | SANIS HEALTH INC | Tablet | MELOXICAM 15 MG | Marketed |
| 02441187 | MELOXICAM ORAL SUSPENSION | ALBERTA VETERINARY LABORATORIES LTD | Suspension | MELOXICAM 15 MG | Marketed |
| 02452170 | MELOXIDYL | CEVA ANIMAL HEALTH INC | Suspension | MELOXICAM 1.5 MG | Approved |
| 02468182 | MELOXIDYL 20 MG/ML | CEVA ANIMAL HEALTH INC | Solution | MELOXICAM 20 MG | Marketed |
| 02542870 | MELOXIKARE CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | MELOXICAM 2.5 MG | Marketed |
| 02542854 | MELOXIKARE CHEWABLE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet (Chewable) | MELOXICAM 1 MG | Marketed |
| 02521458 | MELOXIMED | BIMEDA-MTC ANIMAL HEALTH INC | Solution | MELOXICAM 5 MG | Approved |
| 02532522 | MELOXIMED | BIMEDA-MTC ANIMAL HEALTH INC | Tablet (Chewable) | MELOXICAM 2.5 MG | Approved |
| 02532514 | MELOXIMED | BIMEDA-MTC ANIMAL HEALTH INC | Tablet (Chewable) | MELOXICAM 1 MG | Approved |
| 02318997 | METACAM | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | MELOXICAM 1 MG | Marketed |
| 02319004 | METACAM | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | MELOXICAM 2.5 MG | Marketed |
| 02240463 | METACAM 0.5% INJECTION | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | MELOXICAM 5 MG | Marketed |
| 02330059 | METACAM 20MG/ML SOLUTION FOR INJECTION | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | MELOXICAM 20 MG | Marketed |
| 02529890 | METACAM 40 MG/ML | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | MELOXICAM 40 MG | Marketed |
| 02237715 | METACAM ORAL SUSPENSION | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Suspension | MELOXICAM 1.5 MG | Marketed |
| 02360489 | METACAM ORAL SUSPENSION FOR CATS | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Suspension | MELOXICAM 0.5 MG | Marketed |
| 02567709 | ORTHOXICAM | MODERN VETERINARY THERAPEUTICS LLC | Solution | MELOXICAM 5 MG | Approved |
| 02248268 | PMS-MELOXICAM | PHARMASCIENCE INC | Tablet | MELOXICAM 15 MG | Marketed |
| 02248267 | PMS-MELOXICAM | PHARMASCIENCE INC | Tablet | MELOXICAM 7.5 MG | Marketed |
| 02389932 | RHEUMOCAM 1.5MG/ML ORAL SUSPENSION FOR DOGS | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Suspension | MELOXICAM 1.5 MG | Marketed |
| 02497263 | RHEUMOCAM 15 MG/ML ORAL SUSPENSION | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Suspension | MELOXICAM 15 MG | Marketed |
| 02413868 | RHEUMOCAM INJECTION | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Solution | MELOXICAM 5 MG | Marketed |
| 02452146 | RHEUMOCAM INJECTION | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Solution | MELOXICAM 20 MG | Marketed |
| 02258315 | TEVA-MELOXICAM | TEVA CANADA LIMITED | Tablet | MELOXICAM 7.5 MG | Marketed |
| 02258323 | TEVA-MELOXICAM | TEVA CANADA LIMITED | Tablet | MELOXICAM 15 MG | Marketed |
| 02250020 | ACT MELOXICAM | TEVA CANADA LIMITED | Tablet | MELOXICAM 15 MG | Cancelled Post Market |
| 02250012 | ACT MELOXICAM | TEVA CANADA LIMITED | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02365553 | AVA-MELOXICAM | AVANSTRA INC | Tablet | MELOXICAM 15.0 MG | Cancelled Post Market |
| 02365545 | AVA-MELOXICAM | AVANSTRA INC | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02248605 | DOM-MELOXICAM | DOMINION PHARMACAL | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02248606 | DOM-MELOXICAM | DOMINION PHARMACAL | Tablet | MELOXICAM 15 MG | Cancelled Post Market |
| 02406403 | M-ELOXYN | ZOETIS CANADA INC | Suspension | MELOXICAM 1.5 MG | Dormant |
| 02343428 | MELOXICAM | COBALT PHARMACEUTICALS COMPANY | Tablet | MELOXICAM 15 MG | Cancelled Pre Market |
| 02343401 | MELOXICAM | COBALT PHARMACEUTICALS COMPANY | Tablet | MELOXICAM 7.5 MG | Cancelled Pre Market |
| 02324334 | MELOXICAM | PRO DOC LIMITEE | Tablet | MELOXICAM 15 MG | Cancelled Post Market |
| 02324326 | MELOXICAM | PRO DOC LIMITEE | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02452448 | METACAM FOR SWINE | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | MELOXICAM 5 MG | Cancelled Post Market |
| 02242785 | MOBICOX | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02255987 | MYLAN-MELOXICAM | MYLAN PHARMACEUTICALS ULC | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02255995 | MYLAN-MELOXICAM | MYLAN PHARMACEUTICALS ULC | Tablet | MELOXICAM 15 MG | Cancelled Post Market |
| 02335514 | NU-MELOXICAM | NU-PHARM INC | Tablet | MELOXICAM 15.0 MG | Cancelled (Unreturned Annual) |
| 02335506 | NU-MELOXICAM | NU-PHARM INC | Tablet | MELOXICAM 7.5 MG | Cancelled (Unreturned Annual) |
| 02248607 | PHL-MELOXICAM | PHARMEL INC | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
| 02248608 | PHL-MELOXICAM | PHARMEL INC | Tablet | MELOXICAM 15 MG | Cancelled Post Market |
| 02248031 | RATIO-MELOXICAM | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | MELOXICAM 15 MG | Cancelled Post Market |
| 02247889 | RATIO-MELOXICAM | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | MELOXICAM 7.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1285 | 2000-10-24 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE FROM MOBIC |
| 1297 | 2000-08-31 | New Drug Submission (NDS) |
International API supply for MELOXICAM
10 valid EDQM Certificates of Suitability from 10 holders. 14 active FDA Drug Master Files.
Request a quote for MOBICOX